I-Fibromyalgia yimeko engapheliyo ebonakaliswe ngunxube lweentlungu ezixhaphakileyo kwiimisipha, iintambo, iigaments, ukukhathala, kunye namanqaku amaninzi eethenda emzimbeni. Amaphuzu enkcazo ziindawo ezithile ezibuhlungu okanye zithenda xa uxinzelelo lusetyenziswa, ingakumbi entanyeni, emagxeni, ngasentla, emacaleni, emacaleni, emacaleni, emacaleni nasemathangeni.
Abantu abane-fibromyalgia bangaphinda bafumane ezinye iimpawu kunye neemeko ezinjengokulala okungapheliyo , isifo esilumkileyo esilumkileyo, isifo , intlungu, i- TMJ , ukukhathazeka, ukuxinezeleka , imilenze yokuphunga imilenze , ukuxinwa okanye ukubetha kwizandla kunye neenyawo, ukuxinwa, ukunyamezela, ukuhamba kwexesha , kunye ubukhulu bobukhulu bezinto ezivuthayo, izandi, izibane ezikhanyayo kunye nomnxeba.
Ngokwe-American College yeRheumatology, i-fibromyalgia ithinta abantu abayizigidi ezi-3 ukuya kwezi-6 e-United States. I-Fibromyalgia ixhaphake kakhulu kubasetyhini, ngakumbi phakathi kweminyaka engama-30 no-50.
Iimveliso kunye neZongezelelo zeFibromyalgia
Kuze kube ngoku, inkxaso yenzululwazi yebango lokuba nayiphi na isisombululo sinokuphatha i-fibromyalgia.
1) I-S-adenosylmethionine (i-SAMe)
I-S-adenosylmethionine (i-SAMe) yinkomfa eyenzeka ngokwemvelo emzimbeni. Kufuneka ukuba usebenze ngokufanelekileyo kumzimba womzimba, iimbumba zee cell, i-neurotransmitters ezifana ne-serotonin, i-norepinephrin, ne-dopamine, i-cartilage kunye ne-DNA.
Izifundo ezimbalwa zokuqala zibonisa ukuba i-SAMe inokunceda nge-fibromyalgia. Isifundo esincinci esincinci esiphakambileyo sihlolisise umphumo we-S-adenosylmethionine (i-SAMe) okanye indawo ye-placebo kubantu abangama-17 abane-fibromyalgia, abane-11 abaye bacinezeleka. Inani lamanqaku eethenda linciphile emva kweSAMe kodwa kungekhona indawo. Ukuxinezeleka, njengoko kuhlolwa ngamanqanaba amabini okulinganisa, kuphuculwe emva kwe-SAMe kodwa kungekhona indawo ye-placebo.
Kwesifundo esithile esiphambuka kabini, abantu abangama-44 abane-fibromyalgia bathatha i-800 mg ye-S-adenosylmethionine ngosuku okanye kwindawo ye-placebo. Emva kweiveki ezi-6, kukho ukuphucula okubalulekileyo kwintlungu, ukukhathala, ukuqina komso, ukukhathazeka, kunye nomsebenzi wesifo seklinikhi. Amanqaku amanani, amanqanaba emisipha, kunye nomoya (ukuphononongwa yi-Beck Depression Inventory) akuzange kube ngcono kakhulu kwi-SAMe kune-placebo.
Nangona kunjalo, olunye uphando oluyimpumpo lufanisa uSAMe (600 mg ngosuku) olulawulwe ngaphakathi okanye kwindawo ye-placebo kubantu abangama-34 abane-fibromyalgia. Emva kweentsuku ezili-10, kwakungenohluko oluphawulekayo kumanqaku eethenda.
I-SAM ingabangela ukunyanzelisa, umlomo omile kunye nokulala. Ngokuqhelekileyo, abantu banesifo sohudo esichukumisayo, ukutshaya, ukukhwaza intloko, kunye nesisu.
Abantu abaneengxaki ze-bipolar akufanele bathathe i-SAMe, njengoko kungadlukisayo iziqephu zomntu. Abantu abathatha i-levodopa yeziyobisi (echazwe ngokuqhelekileyo kwisifo se-Parkinson) kufuneka baphephe i-SAMe. Abantu abathatha i-anti-depressants akufanele basebenzise i-SAM ngaphandle kokubonisana nodokotela wabo kuqala. Ukhuseleko lwe-SAMe kwabasetyhini abakhulelweyo okanye abahlengikazi okanye abantwana abazange basungulwe.
2) Magnesium
I-Magnesium iyiminerali efunyenwe ngokwemvelo kwizidalwa ezifana nemifuno eluhlaza, amaqoma, imbewu, kunye ne-grains epheleleyo kunye nezongezelelo zondlo.
I-Magnesium iyadingeka kwiingxelo ezingaphezulu kwama-300 eziphilayo. I-Magnesium, kunye ne-malic acid (isiqhamo se-acid esitholakala ngokwemvelo kwi-apula) sivame ukuphakanyiswa kubantu abane-fibromyalgia kuba zibini zifunekayo ukwenzela ukuveliswa kwamandla kwiiseli ngendlela ye-adenosine triphosphate (ATP). Nangona kunjalo, uphando oluthile lwabantu abangama-97 alufumani nantlangano phakathi kwamanqanaba e-magnesium kunye ne-fibromyalgia.
Ucwaningo oluphindwe kabini luhlolisise ukusebenza nokukhuseleka kwe-magnesium (50 mg kathathu ngosuku) kunye ne-malic acid (200 mg kathathu ngosuku) kubantu abangama-24 abane-fibromyalgia. Emva kweeveki ezi-4, inhlanganisela ye-magnesium / i-malic acid ayizange isebenze ngakumbi kune-placebo.
Abathathi-nxaxheba bafumana emva kweenyanga ezili-6 zokudibanisa kumanani amakhulu (kufika ku-300 mg magnesium kunye ne-1200 mg ye-acid yamicic ngosuku) kwiinyanga ezi-6. Ngeli xesha, ukudibanisa kubangele ukuphucula okukhulu kwintlungu kunye nobubele, nangona kunjalo, le nxalenye yesifundo yayiyilebula evulekileyo (bobabini abaphandi kunye nabathathi-nxaxheba bayazi ukuba yintoni unyango olawulwayo) kwaye bangaboni, ngoko ke iziphumo, ngelixa li thembisa, azikwazi isetyenziswe njengobungqina bokuba ukudibanisa kusebenza. Izifundo ezongezelelweyo zifunekayo.
Amanqanaba aphezulu e-magnesium angabangela isifo sohudo, isisonguluko, ukulahleka kwesidlo, ukungapheli kwemisipha, ukuphefumula ubunzima, uxinzelelo lwegazi oluphantsi, izinga leentliziyo ezingavaliyo kunye nokudideka. Iyakwazi ukusebenzisana namanye amayeza, afana nalawo osteoporosis, uxinzelelo lwegazi oluphezulu (i-calcium channel blockers), kunye nezinye iziza-antibiotics, i-muscle relaxants, kunye ne-diuretics.
3) I-Vitamin D
I-Fibromyalgia kunye nama-aches jikelele kunye neentlungu ezingenakuhlangabezana neendlela zokuxilonga ze-fibromyalgia ziye zabangela abanye abaphandi ukuba babe ne-vitamin D. Ngokomzekelo, isifundo esikhulu saseJamani sahlola abantu abangama-994 kwaye safumana ukulungelelanisa okunamandla phakathi kwamanqanaba aphantsi e-vitamin D kunye namazinga aphakamileyo kunye nobude obude beethambo jikelele kunye / okanye imisipha yomzimba kunye neentlungu.
Uphando olupapashwe kwi- Mayo Clinic Proceedings luhlolisise abantu abangama-150 abaneentlungu ezingapheliyo, ezingezizo ezixubileyo eMunscow. Abaphandi bafumanisa ukuba i-93% yazo yayinamaqondo alamandla e-vitamin D.
Kwesinye isifundo, amazinga e-vitamin D ahlolwe ngabantu abangama-75 abazalisekisa i-American College ye-Rheumatology criteria ye-fibromyalgia. Nangona bekungekho ubudlelwane phakathi kwamanqanaba e-vitamin D kunye neempawu ze-musculoskeletal, ukulahleka kwe-vitamin D kwakudibene nokuxhalaba nokudandatheka kubantu abane-fibromyalgia.
4) 5-hydroxytryptophan (5-HTP)
Ukongezwa kwe-5-HTP kucingelwa ukuba isebenze ngokunyuka kwamazinga we-neurotransmitter serotonin kwingqondo. Kukho ubungqina bokuqala bokuthi kunokunciphisa inani lamanqaku eethenda kubantu abane-fibromyalgia, mhlawumbi ngokuvelisa iinkqubo zokumanyanisa iintlungu kwi-brainstem.
Ucwaningo oluthathwa ngokuphindaphindiweyo, lubekwe i-placebo lubhekisele kwi-5-HTP okanye indawo ye-placebo kubantu abangama-50 abane-fibromyalgia. Emva kweeveki ezine, abantu abathatha i-5-HTP babenokuphucuka okubalulekileyo kwintlungu, inani lamanqaku eethenda, ukuqina, ukuxhala, ukukhathala nokulala. Imiphumo emibi yayimnene kwaye idlulileyo. Ukufumana ulwazi oluninzi, funda i-5-HTP Fact Sheet.
5) I-Vitamin B12
Uphando lweSweden lubonise amaqondo aphantsi avithamini B12 kwi-cerebrospinal fluid yabantu abane fibromyalgia kunye nesifo esingapheliyo.
Abafazi abalishumi elinesibini abaye badibanisa imigaqo yokubamba i-fibromyalgia kunye nesifo esingapheliyo isifo sokufunda, kunye neqela elilawulayo labasetyhini abaneempilweni.
> Amanqanaba e-homocysteine kwi-cerebrospinal fluid ayedlula ngokuphindwe kathathu kwabafazi ababenomzimba we-fibromyalgia kunye nesifo esingapheliyo ukugula xa kuthelekiswa neqela lokulawula. Amanqanaba e-vitamin B12 e-Cerebrospinal ayenamanzi athatyathwa ngabantu aba-7 kwabangu-12 abane-fibromyalgia kunye nesifo esingapheliyo.
6) ICapsaicin Cream
I-Capsaicin (i-cap-SAY-sin) eyaziwayo iyisithako esisebenzayo kwi-pepper. Kucingelwa ukuba kunciphise intlungu.
Xa isetyenziswe kwesikhumba, i-capsaicin cream ifunyenwe ukuba ikhuphe imveliso yeP, i-neurochemical ehambisa intlungu, eyenza umntu aveze intlungu. Abantu abane-fibromyalgia baye bafumanisa ukuba banamazinga aphezulu okwendalo.
Olunye uphando luhlolisise ukusebenza kwe-capsaicin kwi-fibromyalgia. Abathathi-nxaxheba kweso sifundo bafaka i-0.025% ye-capsaicin cream kane ngeentsuku kumanqaku amathenda. Emva kweeveki ezi-4, banciphise intlungu. Ukufumana ulwazi olongezelelweyo kuquka nemiphumo emibi kunye nokukhathazeka kokukhuseleko, funda i- Capsaicin Cream Fact Sheet .
Ukusebenzisa iziNyango zeNdalo zeFibromyalgia
Ngenxa yokungabikho kokuxhasa uphando, kungekudala ukucebisa ezinye iindlela zokwelapha kwi-fibromyalgia unyango. Ukongezelela, izongezelelo azange zivavanywe ukhuseleko kwaye ngenxa yokuba izongezo zokutya zikhululekile kakhulu, umxholo weemveliso ezithile zingahluka kwizinto ezichazwe kwileyibhile yomveliso.
Kwakhona khumbula ukuba ukhuseleko lwezongezelelo kwabasetyhini abakhulelweyo, oomama abanamancela, abantwana kunye nalabo abanezifo zonyango okanye abathabatha imishanguzo ayilwanga. Unokufumana iingcebiso ekusebenziseni izongezo apha , kodwa ukuba ucinga ngokusetyenziswa kwamachiza athile, ncokola nomboneleli wakho oyintloko. Ukuziphathela imeko kunye nokuphepha okanye ukulibazisa ukunakekelwa okuqhelekileyo kunokuba nemiphumo emibi.
> Imithombo:
> Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, i-Finch MB. KwiKliniki yaseRheumatol. 2006 Julayi 19. [Epub phambi kokuprintwa) Ubunzima beVitamin D budibene nokuxhalabisa nokudandatheka kwi-Fibromyalgia.
> Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabrini L, Italian P, De Feo F, Giuliano T, Giacomelli C, Rossi A, Lucacchini A, Bombardieri S. Ukuguqulwa kweSerotonin Transporter Ukunyaniseka kunye nomsebenzi kwi-Fibromyalgia. Arthritis Res Ther. 8.4 (2006): R99.
> UCaruso I, uSarzi Puttini P, uCazzola M, Azzolini V. Ukufunda okuBili-2-Hydroxytryptophan ne-Placebo kwiNyango ye-Primary Fibromyalgia Syndrome. J Int Med Res. 18.3 (1990): 201-209.
> Erkal MZ, Wilde J, Bilgin Y, Akinci A, Demir E, > Bodeker > RH, Mann M, Bretzel RG, Stracke H, Holick MF. Ukuphakama okuphezulu kwe-Vitamin D, i-Hyperparathyroidism kunye neSondalized Bone Pain eTurkey e-Jamani: I-Identification of Factors Risk. Osteoporos Int. 17.8 (2006): 1133-1140.
> UHelwell PS, u-Ibrahim GH, uKarim Z, > uSokoll > K, uJohnson H. Ubuhlungu obungasichazwanga boMasculoskeletal kuBantu base-Asia yase-Asia babhekiselwa kwikliniki yeRheumatology - Ubudlelwane ne-Biochemical Osteomalacia, Ukunyamezela ixesha kunye nokuphendula kwindlela yokwelashwa ngeCalcium ne-Vitamin D. Iiklinikhi yeRheumatol. 24.4 (2006): 424-427.
> Jacobsen S, Danneskiold-Samsoe B, Andersen RB. I-Oral S-Adenosylmethionine kwi-Primary Fibromyalgia. UkuVavanywa kweZikliniki eziBini. Scand J Rheumatol. 20.4 (1991): 294-302.
> IPlotnikoff GA, Quigley JM. Ubuninzi be-Hyverevitaminosis D enamandla kwizigulane eziqhubekayo, ubuhlungu obungama-musculoskeletal. IMayo Clin Proc. 78.12 (2003): 1463-1470.
> Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Iingqwalaselo ezandisiweyo ze-Homocysteine kwi-Cerebrospinal Fluid kwizigulane ezine-Fibromyalgia ne-Chronicly Fatigue Syndrome. Scand J Rheumatol. 26.4 (1997): 301-307.
> Tavoni A, Vitali C, iBombardieri S, Pasero G. Ukuvavanywa kwe-S-Adenosylmethionine kwi-Fibromyalgia yaseprayimari. Isifundo se-Double-Blind Crossover. Am J Med. 83.5A (1987): 107-110.
> Volkmann H, uNorregaard J, uJacsensen S, uDanneskiold-Samsoe B, uKnoke G, uNehrdich D. I-Double-Blind, i-Placebo-Control-Over Study ye-Intravenous S-Adenosyl-L-Methionine kwizigulane nge-Fibromyalgia. Scand J Rheumatol. 26.3 (1997): 206-211.
> Wahner-Roedler DL, Elkin PL, Vincent A, JM Thompson, Oh TH, Loehrer LL, Mandrekar JN, uBauer BA. Ukusetyenziswa kweZonyango eziPheleleyo kunye nezinye iindlela zeZonyango ezibhekiselele kwiNkqubo yoLonyango lwe-Fibromyalgia kwiziko loLondolozo lweMfundo ePhakamileyo. IMayo Clin Proc. 80.1 (2005): 55-60.
Ulwazi oluqulethwe kule ndawo lujoliswe kwiinjongo zemfundo kuphela kwaye alithathi indawo yeengcebiso, ukuxilongwa okanye unyango ngumgqirha onikwe ilayisenisi. Akunakuthetha ukukhusela zonke iindlela zokulondoloza, ukusebenzisana kwezidakamizwa, imeko okanye imiphumo emibi. Kufuneka uncede unyango lwangonyango ngokukhawuleza kuyo nayiphi na imiba yempilo uze ubonane nodokotela wakho ngaphambi kokusebenzisa elinye iyeza okanye wenze utshintsho kwi-regimen yakho.